The results showed that CCH markedly upregulated Hdac6 protein levels, which were significantly downregulated by FMT and SCFAs (Figure 5F,G), indicating that this treatment strategy could ameliorate CCH‐induced cognitive dysfunction partly via the inhibition of HDACs. This evidence concerns the gene HDAC6 and columnar cell hyperplasia of the breast.